Search clinical trials for: lispro

Total 330 results

Eli Lilly and Company

Completed

A Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants

Diabetes Mellitus, Type 2

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Healthy Participants

Healthy

Singapore
Diasome Pharmaceuticals

Completed

Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec

Diabetes Mellitus, Type 1

United States
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Type 2 Diabetes Mellitus

United States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
Nanfang Hospital of Southern Medical University

Completed

Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy

Diabetic Nephropathies
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib

Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer

United States
Gan and Lee Pharmaceuticals, USA

Completed

PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males

Diabetes Mellitus

Germany
Gan and Lee Pharmaceuticals, USA

Withdrawn

Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro (GENTL 1)

Diabetes Mellitus, Type 1

United States, Spain, Hungary, Poland, Germany, Czechia
Massachusetts General Hospital

Completed

The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

Type1 Diabetes Mellitus

United States
Emory University

Completed

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery (SITA-CABGDM)

Hyperglycemia

United States
Novartis Pharmaceuticals

Completed

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Acromegaly

Italy, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
Merck Sharp & Dohme LLC

Completed

Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Diabetes Type 1

United States, Spain
Dance Biopharm Inc.
Profil Institut für Stoffwechselforschung GmbH

Completed

Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus

Germany
Eli Lilly and Company

Completed

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) (AWARD-7)

Type 2 Diabetes | Chronic Kidney Disease

Mexico, United States, Hungary, Ukraine, Brazil, Spain, Romania, South Africa, Poland
Dance Biopharm Inc.
WCCT Global

Terminated

PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Safety and Tolerability

United States
Massachusetts General Hospital

Completed

The Insulin-Only Bionic Pancreas Bridging Study

Type1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

Assessment of Mealtime Bolus Insulin Behavior

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Geropharm

Completed

Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Eli Lilly and Company

Completed

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Mario Negri Institute for Pharmacological Research
AstraZeneca

Unknown

Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib (BAROCCO)

Ovarian Neoplasms

Italy
Eli Lilly and Company

Completed

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges

Type 1 Diabetes Mellitus

United States
Adocia

Completed

A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Ain Shams University
Drug Research Centre, Cairo, Egypt

Completed

The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin

Diabetes Mellitus | Pharmacokinetics | Pharmacodynamics

Egypt
Eli Lilly and Company

Completed

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

Diabetes Mellitus, Type 1

United States
Eli Lilly and Company

Completed

A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements

Diabetes Mellitus, Type 1

Germany
Halozyme Therapeutics

Completed

Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
Halozyme Therapeutics

Completed

Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20

Diabetes Mellitus

United States
Halozyme Therapeutics

Completed

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

United States
Halozyme Therapeutics

Completed

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Type 1 Diabetes Mellitus

United States
Adocia

Completed

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Emory University
Boston Medical Center; Rush University; University of Denver

Completed

Linagliptin Inpatient Trial

Type 2 Diabetes

United States
Medical University of Vienna
Medical University of Graz; Charite University, Berlin, Germany; Hospital del...

Completed

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients (ITP-NODAT)

Hyperglycemia
Eli Lilly and Company

Completed

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)

Type 1 Diabetes Mellitus

United States
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) (CASPS)

Alveolar Soft-part Sarcoma

Australia, United Kingdom, Spain
University of Texas Southwestern Medical Center

Withdrawn

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Type 1 Diabetes

United States
Emory University
Merck Sharp & Dohme LLC

Completed

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Hyperglycemia | Type 2 Diabetes Mellitus | Hospitalization

United States
National Cancer Institute (NCI)

Completed

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Recurrent Rectal Carcinoma | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Stage IVA Rectal Cancer AJCC v7 | Stage IVB Rectal Cancer AJCC v7 | Rectal Mucinous Adenocarcinoma | Rectal Signet Ring Cell Adenocarcinoma | Stage IIA Rectal Cancer... and other conditions

United States
Halozyme Therapeutics

Completed

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Type 1 Diabetes Mellitus

United States
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics

Diabetes Mellitus, Type 2

United States
University of Hull

Completed

Environmental Effects Type 1 Diabetes Mellitus

Type1diabetes

United Kingdom
Uppsala University
Göteborg University

Unknown

Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes (AIDIT)

Glucose Metabolism Disorders | Inflammation | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Diet Modification | Type 1 Diabetes Mellitus | Metabolic Disease | Juvenile Diabetes | Insulin Dependent Diabetes

Sweden
Medical University of Graz
Medical University of Vienna; Medical University Innsbruck; Klinikum Klagenfurt... and other collaborators

Unknown

Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert

Induction of Labor | Cervical Ripening

Austria
Mount Sinai Hospital, Canada
Canadian Institutes of Health Research (CIHR)

Completed

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

Type 2 Diabetes

Canada

Search clinical trials for: lispro

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations